Quarterly Result30 Jul 2025, 02:26 pm
Acutaas Chemicals Q1 FY26 Results: Revenue from Operations at 2,072mn, up 17.3% YoY
AI Summary
Acutaas Chemicals Limited, a leading global manufacturer of advance pharmaceutical intermediates and speciality chemicals, announced financial results for the quarter ended June 30, 2025. The company reported a 17.3% year-on-year growth in revenue from operations, driven by a robust performance in the Pharmaceutical Intermediates business. Both pharma facilities are now PMDA GMP certified, underscoring the commitment to global compliance and quality. Acutaas Chemicals has also entered into a joint venture in South Korea, bringing it closer to key semiconductor markets and strengthening its portfolio with differentiated, high-value products tailored for this space.
Key Highlights
- Q1FY26 Revenue from operations grew by 17.3% YoY to Rs. 2,072 mn
- Gross margin improved to 53.2% up 1,117 bps YoY
- EBITDA for the quarter came at Rs. 509 mn up 72.4% YoY
- EBITDA margin for the quarter was at 24.6% as compared to 16.7% in QIFY25
- PAT for the quarter was Rs. 440 mn up 199.6% as compared to PAT of Rs. 147 mn in QiFY25
- Export for the quarter at 60%; domestic business at 40%